# Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Patients With Type 1 Diabetes

> **NCT00703599** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Adistem Ltd** · enrollment: 30 (estimated)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **PROCEDURE:** Autologous Adipose-derived Stem cells

## Key facts

- **NCT ID:** NCT00703599
- **Lead sponsor:** Adistem Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-11
- **Primary completion:** 2009-11
- **Final completion:** 2009-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2008-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00703599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00703599, "Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Patients With Type 1 Diabetes". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00703599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*